Related Experiment Video
Updated: Aug 20, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway
Yonghe Li1, Yaolin Yin1, Yi He1
1Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.
Abstract:
The influence of son of sevenless homolog 1 (SOS1) on invasion and metastasis of hepatocellular carcinoma (HCC) cells was investigated. HCC cells were transfected with siRNA and lentivirus to achieve SOS1 knock down/overexpression and changes in RNA and protein levels analyzed by q-PCR and Western blotting (WB). Transwell assay was utilized to assess variations in cell invasion and migration in vitro and by a lung metastasis model of liver cancer in vivo. High expression of SOS1 was observed in most human liver cancers, which indicated a worse prognosis. SOS1 knockout in HepG2 cells significantly decreased cell invasion and migration. SOS1 knockout also reduced the number of metastatic foci in a lung metastasis model of HCC established in nude mice. SOS1 knockout inhibited the epithelial-mesenchymal transition (EMT) in HepG2 cells as well as the PI3K/AKT/mTOR pathway. Overexpression of SOS1 in Huh7 cells had the opposite effect. To conclude, SOS1 may induce the EMT by the activation of the PI3K/AKT/mTOR pathway, thereby enhancing invasion, migration and metastasis of HCC cells. These findings may expose SOS1 as a new HCC therapeutic target.
Insights
Son of sevenless homolog 1 (SOS1) promotes hepatocellular carcinoma (HCC) invasion and metastasis by activating the PI3K/AKT/mTOR pathway and epithelial-mesenchymal transition (EMT). Targeting SOS1 may offer a new therapeutic strategy for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern with limited effective treatments.
- Understanding the molecular mechanisms driving HCC invasion and metastasis is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of son of sevenless homolog 1 (SOS1) in the invasion and metastasis of hepatocellular carcinoma (HCC) cells.
- To explore the underlying molecular pathways, including epithelial-mesenchymal transition (EMT) and the PI3K/AKT/mTOR pathway, influenced by SOS1.
Main Methods:
- SOS1 knockdown and overexpression were achieved in HCC cell lines (HepG2, Huh7) using siRNA and lentivirus.
- Quantitative PCR (q-PCR) and Western blotting (WB) were used to analyze gene and protein expression levels.
- Transwell assays assessed cell invasion and migration in vitro, and a lung metastasis model evaluated in vivo metastatic potential.
Main Results:
- High SOS1 expression correlated with worse prognosis in human HCC.
- SOS1 knockout significantly reduced HCC cell invasion, migration, and lung metastasis in mice.
- SOS1 inhibition suppressed EMT and the PI3K/AKT/mTOR pathway in HCC cells, while SOS1 overexpression had opposite effects.
Conclusions:
- SOS1 promotes HCC invasion, migration, and metastasis, potentially by inducing EMT via activation of the PI3K/AKT/mTOR pathway.
- SOS1 represents a promising therapeutic target for hepatocellular carcinoma.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...